Chemical Structure (Methylphenidate Hydrochloride Extended Release Tab 1)
Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 62175-310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 62175-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)
This is a chart displaying the mean plasma concentration of two different dosages of methylphenidate HCI over a 24-hour period. One dosage is 18 mg taken once daily and the other is 5 mg taken three times daily. The chart shows the concentration of methylphenidate in the blood measured in ng/mL at different time intervals.*
Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)
This appears to be a table or chart with medication dosages listed for a study. It is unclear what the study is for or what the other columns in the chart represent. Not enough information is available to provide a useful description.*
Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)
18 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 5)
27 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 6)
This is a description for a medication called Methylphenidate HCI Extended-Release Tablets, USP 27 mg. The text provides instructions for usage, storage temperature, and protection against humidity. It also notes the pharmaceutical company that manufactures the medication and a product code. The description includes a reminder for pharmacists to dispense a medication guide to each patient and a website where the guide can be printed.*
36 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 7)
This is a medication description for Methylphenidate HCI Extended-Release Tablets, USP containing 36mg. The tablets should be stored at room temperature and protected from humidity. It is manufactured by Kremes Urban Pharmaceuticals Inc. in Seymour, IN. The medication should be dispensed with a medication guide for the patient and is available online.*
54 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 8)
This is a description of a medication called Methylphenidate HCl Extended-Release Tablets, USP with a concentration of 54 mg. It is manufactured by Krommens L Phermacaufios. The medication comes with an accompanying Modification Guide for patients. It should be stored at a controlled temperature of around 25°C (77°F) and should be protected from humidity. The dosage and usage instructions are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
